Russell Matthew Wolbers, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-333-5651 |
Lea Chien, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-333-5111 |
Clinton Jeffery Hartman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4102 Pinion Dr, 10th Mdg, Usaf Academy, CO 80840 Phone: 719-333-5691 |
Annette Susan Gablehouse, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-333-5961 |
Dr. Lindsay B Howard, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 281-387-5169 |
Stacey Alicia Vandyke, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4102 Pinion Dr, Usaf Academy, CO 80840 Phone: 719-333-5651 |
Mrs. Krista Lynn Christianson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4102 Pinion Dr, 10th Medical Group, Usaf Academy, CO 80840 Phone: 719-333-5691 |
News Archive
Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.
The Department of Health and Human Services is sending $229 million in exchange establishment grants to 10 states - half of which are receiving this funding for a second time around. However, an Associated Press analysis found that progress among states in setting up these health insurance marketplaces remains uneven.
Nexxus, the West of Scotland Bioscience Network will hold the second event of the Horizons in Biomedicine Series today at 6.30pm at the Glasgow Science Centre.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 6 days ago